Green Tea Extract for Cancer-Related Nerve Pain
(GTE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether green tea extract can reduce nerve pain in cancer survivors receiving supportive care. Researchers aim to determine if daily green tea extract can lessen this pain compared to a placebo (a substance with no active treatment). The trial targets individuals with cancer-related nerve pain whose pain management has remained stable recently. Those who do not regularly consume large amounts of green tea and are not allergic to rice may qualify. As a Phase 2 trial, this research focuses on assessing the treatment's effectiveness in an initial, smaller group of participants.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop your current medications, but you must have a stable pain management regimen with no more than a 10% change in dosage in the 14 days before joining.
Is there any evidence suggesting that this treatment is likely to be safe for humans?
Research has shown that green tea extract (GTE) might protect the brain and nerves. Some studies suggest it can aid in healing nerve injuries. However, reports have noted mild to moderate side effects, such as stomach issues, headaches, and heart-related problems. These side effects were usually mild and resolved after stopping the treatment. It's important to note that this treatment remains in the early stages of testing. While some evidence indicates it is safe, more research is needed to fully understand its effects.12345
Why do researchers think this study treatment might be promising?
Unlike the standard treatments for cancer-related nerve pain, which often include medications like opioids or anticonvulsants, the green tea extract being studied is derived from a natural source: the decaffeinated green tea leaf. Researchers are excited because this extract may offer pain relief without the side effects commonly associated with current medications, such as drowsiness or addiction potential. Additionally, green tea is known for its antioxidant properties, which could provide added benefits in managing nerve pain associated with cancer.
What evidence suggests that green tea extract might be an effective treatment for cancer-related nerve pain?
Research has shown that green tea extract (GTE) might help reduce nerve pain in cancer patients. One study found that GTE improved pain symptoms after eight weeks. Another small study suggested it could help with nerve pain caused by cancer treatments. In this trial, participants will receive either GTE or a placebo to evaluate its effectiveness. Although more research is needed, these early results are promising for using GTE as a natural way to ease nerve pain.14678
Who Is on the Research Team?
Michael Daniel, PhD
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for adults who are cancer survivors experiencing nerve pain (neuropathic pain) related to their cancer or its treatment, and who are receiving supportive palliative care. People with certain medical conditions or on conflicting medications may not be eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive daily, oral, encapsulated green tea extract (GTE) or placebo to mitigate neuropathic pain
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Green Tea Leaf Extract Decaffeinated
Trial Overview
The study tests whether taking a daily capsule of decaffeinated green tea extract can help reduce nerve pain in cancer survivors compared to a placebo (inactive pill). Participants are randomly assigned to either the green tea extract or placebo group.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Citations
1.
trial.medpath.com
trial.medpath.com/clinical-trial/0b30b613d39aad04/nct07682324-green-tea-extract-mitigate-neuropathic-pain-cancerDaily, Encapsulated, Green Tea Extract to... | Clinical Trial
The overall objective of this study is to test an intervention of green tea extract (GTE) to mitigate neuropathic pain in patients, ...
Effect of green tea extracts on oxaliplatin-induced peripheral ...
Green tea extracts may be a useful adjuvant to alleviate sensory symptoms after oxaliplatin administration, such as allodynia, but did not prevent morphometric
Daily, Encapsulated, Green Tea Extract to Mitigate ...
The overall objective of this study is to test an intervention of green tea extract (GTE) to mitigate neuropathic pain in patients, specifically ...
A Pilot Study: Comparative Effects of Green Tea Extract ...
The preliminary findings from this pilot study suggest that GTE may be an effective, nutraceutical intervention for mitigating OIPN-associated neuropathic pain,
Green Tea
Green tea reduced the risk of recurrence in breast cancer patients (72), but regular consumption may elevate the risk in some postmenopausal ...
A Pilot Study: Comparative Effects of Green Tea Extract and ...
Several studies have demonstrated that EGCG provides protection against both central and peripheral nervous system injuries in preclinical ...
Adverse Effects Reported with Concentrated Green Tea ...
Mild-to-moderate toxicities (gastrointestinal, neurological, and cardiovascular effects) were seen at most dose levels and were promptly reversed on ...
Therapeutic Effects of Phytochemicals and Medicinal ...
Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent adverse effect of neurotoxic anticancer medicines. It leads to autonomic and somatic system ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.